Open Access
RESIDENT’S CORNER
Neuroendocrine transformation of prostate adenocarcinoma with corpora cavernosa metastases
Halle Foss1, Radhika Ragam1, W. Kevin Kelly2, Leonard G. Gomella1
1 Department of Urology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA
2 Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA
Address correspondence to Dr. Halle Foss, Department of Urology, Thomas Jefferson University Hospital, 1025 Walnut Street, Suite 1100, Philadelphia, PA 19107 USA
Canadian Journal of Urology 2022, 29(6), 11399-11401.
Abstract
We report the case of a 61-year-old male with metastatic prostate cancer who presented with urinary retention secondary to subdermal penile and corpora cavernosa metastases with neuroendocrine transformation of his metastatic hormone sensitive prostate cancer. We highlight the presentation, diagnosis, and management of this rare condition.
Keywords
neuroendocrine prostate cancer, neuroendocrine transformation, small cell carcinoma, genomics, RB1 loss
Cite This Article
APA Style
Foss, H., Ragam, R., Kelly, W.K., Gomella, L.G. (2022). Neuroendocrine transformation of prostate adenocarcinoma with corpora cavernosa metastases. Canadian Journal of Urology, 29(6), 11399–11401.
Vancouver Style
Foss H, Ragam R, Kelly WK, Gomella LG. Neuroendocrine transformation of prostate adenocarcinoma with corpora cavernosa metastases. Can J Urology. 2022;29(6):11399–11401.
IEEE Style
H. Foss, R. Ragam, W.K. Kelly, and L.G. Gomella, “Neuroendocrine transformation of prostate adenocarcinoma with corpora cavernosa metastases,” Can. J. Urology, vol. 29, no. 6, pp. 11399–11401, 2022.
Copyright © 2022 The Canadian Journal of Urology.